Scribe Therapeutics, Inc.
SCTXNasdaq
$21.65
Jul 24 close · end-of-day
Price
No price history ingested.
Key statistics
No screener snapshot for this ticker.
Company profile
We are a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention. Our principal executive offices are located in Alameda, California.
- CEO
- Benjamin L. Oakes
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 89
- Headquarters
- California
- Website
- www.scribetx.com
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions · last 12 months
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.